{
      "Rank": 1,
      "Acronym": [
            "SCOTS2"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "BMSC provided retrobulbar, subtenon and intravenous for one or both eyes"
      ],
      "ArmGroupInterventionName": [
            "Procedure: Arm 1"
      ],
      "ArmGroupLabel": [
            "Arm 1"
      ],
      "ArmGroupType": [
            "Other"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03011541"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease."
      ],
      "BriefTitle": [
            "Stem Cell Ophthalmology Treatment Study II"
      ],
      "CentralContactEMail": [
            "stevenlevy@mdstemcells.com"
      ],
      "CentralContactName": [
            "Steven Levy, MD",
            "Steven Levy, MD"
      ],
      "CentralContactPhone": [
            "203-423-9494",
            "203-423-9494"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "July 2024"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Retinal Disease",
            "Age-Related Macular Degeneration",
            "Retinitis Pigmentosa",
            "Stargardt Disease",
            "Optic Neuropathy",
            "Nonarteritic Ischemic Optic Neuropathy",
            "Optic Atrophy",
            "Optic Nerve Disease",
            "Glaucoma",
            "Leber Hereditary Optic Neuropathy",
            "Blindness",
            "Vision Loss Night",
            "Vision Loss Partial",
            "Vision, Low",
            "Retinopathy",
            "Maculopathy",
            "Macular Degeneration",
            "Retina Atrophy"
      ],
      "ConditionAncestorId": [
            "D000005128",
            "D000009468",
            "D000012162",
            "D000020763",
            "D000015785",
            "D000058499",
            "D000030342",
            "D000003389",
            "D000014786",
            "D000012678",
            "D000009461",
            "D000014652",
            "D000002318",
            "D000015418",
            "D000020271",
            "D000019636",
            "D000028361",
            "D000008659"
      ],
      "ConditionAncestorTerm": [
            "Eye Diseases",
            "Neuromuscular Diseases",
            "Retinal Degeneration",
            "Pathological Conditions, Anatomical",
            "Eye Diseases, Hereditary",
            "Retinal Dystrophies",
            "Genetic Diseases, Inborn",
            "Cranial Nerve Diseases",
            "Vision Disorders",
            "Sensation Disorders",
            "Neurologic Manifestations",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Optic Atrophies, Hereditary",
            "Heredodegenerative Disorders, Nervous System",
            "Neurodegenerative Diseases",
            "Mitochondrial Diseases",
            "Metabolic Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC11",
            "All",
            "BC16",
            "BC23",
            "BC10",
            "BC20",
            "BC18",
            "BC09",
            "BC14",
            "BC26",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Eye Diseases",
            "All Conditions",
            "Diseases and Abnormalities at or Before Birth",
            "Symptoms and General Pathology",
            "Nervous System Diseases",
            "Immune System Diseases",
            "Nutritional and Metabolic Diseases",
            "Ear, Nose, and Throat Diseases",
            "Heart and Blood Diseases",
            "Wounds and Injuries",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Retinitis",
            "Retinitis Pigmentosa",
            "Atrophy",
            "Macular Degeneration",
            "Retinal Disease",
            "Optic Neuropathy",
            "Leber's Hereditary Optic Neuropathy",
            "Vision, Low",
            "Blindness",
            "Stargardt Disease",
            "Ischemic Optic Neuropathy",
            "Optic Atrophy",
            "Neuropathy",
            "Retinitis Pigmentosa",
            "Leber's Hereditary Optic Neuropathy",
            "Stargardt Disease",
            "Ischemic Optic Neuropathy"
      ],
      "ConditionBrowseLeafId": [
            "M7423",
            "M14160",
            "M14161",
            "M28260",
            "M15507",
            "M11566",
            "M3741",
            "M10412",
            "M9695",
            "M27888",
            "M14151",
            "M8165",
            "M11320",
            "M11984",
            "M22575",
            "M27865",
            "M17194",
            "M4199",
            "M2147",
            "M26161",
            "M1898",
            "M851",
            "M20106",
            "M21200",
            "M11843",
            "M11979",
            "M22574",
            "M12584",
            "M17245",
            "M11563",
            "M14149",
            "M21672",
            "M17491",
            "M22839",
            "M5757",
            "M16682",
            "M14642",
            "M11556",
            "M16552",
            "M21245",
            "M20711",
            "M22494",
            "M10791",
            "T4945",
            "T4103",
            "T3352",
            "T5470",
            "T5809",
            "T1444",
            "T1446",
            "T1448",
            "T429",
            "T1915",
            "T4257"
      ],
      "ConditionBrowseLeafName": [
            "Eye Diseases",
            "Retinitis",
            "Retinitis Pigmentosa",
            "Retinal Dystrophies",
            "Syndrome",
            "Neuromyelitis Optica",
            "Atrophy",
            "Macular Degeneration",
            "Ischemia",
            "Wet Macular Degeneration",
            "Retinal Diseases",
            "Glaucoma",
            "Myopia",
            "Optic Nerve Diseases",
            "Optic Atrophy, Hereditary, Leber",
            "Geographic Atrophy",
            "Vision, Low",
            "Blindness",
            "Stargardt Disease",
            "Usher Syndromes",
            "Cone Dystrophy",
            "Cone-Rod Dystrophies",
            "Optic Neuropathy, Ischemic",
            "Optic Nerve Injuries",
            "Night Blindness",
            "Optic Atrophy",
            "Optic Atrophy, Autosomal Dominant",
            "Peripheral Nervous System Diseases",
            "Optic Atrophies, Hereditary",
            "Neuromuscular Diseases",
            "Retinal Degeneration",
            "Pathological Conditions, Anatomical",
            "Eye Diseases, Hereditary",
            "Genetic Diseases, Inborn",
            "Cranial Nerve Diseases",
            "Vision Disorders",
            "Sensation Disorders",
            "Neurologic Manifestations",
            "Vascular Diseases",
            "Heredodegenerative Disorders, Nervous System",
            "Neurodegenerative Diseases",
            "Mitochondrial Diseases",
            "Metabolic Diseases",
            "Retinitis Pigmentosa",
            "Neuromyelitis Optica Spectrum Disorder",
            "Leber Hereditary Optic Neuropathy",
            "Stargardt Disease",
            "Usher Syndrome",
            "Cone Dystrophy",
            "Cone-rod Dystrophy",
            "Cone-rod Dystrophy 2",
            "Anterior Ischemic Optic Neuropathy",
            "Dominant Optic Atrophy",
            "Optic Atrophy 1"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "high",
            "high",
            "low",
            "low",
            "high",
            "low",
            "low",
            "high",
            "high",
            "low",
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "high",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000010523",
            "D000009901",
            "D000001766",
            "D000018917",
            "D000029242",
            "D000009422",
            "D000009896",
            "D000015354",
            "D000008268",
            "D000012164",
            "D000012173",
            "D000012174",
            "D000080362",
            "D000001284"
      ],
      "ConditionMeshTerm": [
            "Peripheral Nervous System Diseases",
            "Optic Nerve Diseases",
            "Blindness",
            "Optic Neuropathy, Ischemic",
            "Optic Atrophy, Hereditary, Leber",
            "Nervous System Diseases",
            "Optic Atrophy",
            "Vision, Low",
            "Macular Degeneration",
            "Retinal Diseases",
            "Retinitis",
            "Retinitis Pigmentosa",
            "Stargardt Disease",
            "Atrophy"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [
            "Single Arm- Arm 1. Comparator is natural history of the disease."
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Eyes with loss of vision from retinal or optic nerve conditions generally considered irreversible will be treated with a combination of injections of autologous bone marrow derived stem cells isolated from the bone marrow using standard medical and surgical practices. Retinal conditions may include degenerative, ischemic or physical damage ( examples may include macular degeneration, hereditary retinal dystrophies such as retinitis pigmentosa, stargardt, non-perfusion retinopathies, post retinal detachment. Optic Nerve conditions may include degenerative, ischemic or physical damage ( examples may include optic nerve damage from glaucoma, compression, ischemic optic neuropathy, optic atrophy ). Injections may include retrobulbar, subtenon, intravitreal, intraocular, subretinal and intravenous. Patients will be followed for 12 months with serial comprehensive eye examinations including relevant imaging and diagnostic ophthalmic testing."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nHave objective, documented damage to the retina or optic nerve unlikely to improve OR\nHave objective, documented damage to the retina or optic nerve that is progressive AND have less than or equal to 20/30 best corrected central visual acuity in one or both eyes AND/OR an abnormal visual field in one or both eyes.\nBe at least 3 months post-surgical treatment intended to treat any ophthalmologic disease and stable.\nIf under current medical therapy ( pharmacologic treatment) for a retinal or optic nerve disease be considered stable on that treatment and unlikely to have visual function improvement ( for example, glaucoma with intraocular pressure stable on topical medications but visual field damage ).\nHave the potential for improvement with BMSC treatment and be at minimal risk of any potential harm from the procedure.\nBe over the age of 18\nBe medically stable and able to be medically cleared by their primary care physician or a licensed primary care practitioner for the procedure.\nMedical clearance means that in the estimation of the primary care practitioner, the patient can reasonably be expected to undergo the procedure without significant medical risk to health.\n\nExclusion Criteria:\n\nPatients who are not capable of an adequate ophthalmologic examination or evaluation to document the pathology.\nPatients who are not capable or not willing to undergo follow up eye exams with the principle investigator or their ophthalmologist or optometrist as outlined in the protocol.\nPatients who are not capable of providing informed consent.\nPatients who may be at significant risk to general health or to the eyes and visual function should they undergo the procedure."
      ],
      "EnrollmentCount": [
            "500"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [
            "The investigators do not plan to share individual participant data (IPD)"
      ],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Arm 1"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Procedure/ Surgery: RB (Retrobulbar)\n\nRetrobulbar injection of Bone Marrow Derived Stem Cells (BMSC)\n\nProcedure/Surgery: ST (Subtenon)\n\nSubtenon injection of Bone Marrow Derived Stem Cells (BMSC)\n\nProcedure/Surgery: IV (Intravenous)\n\nIntravenous injection of Bone Marrow Derived Stem Cells (BMSC)"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Arm 1"
      ],
      "InterventionOtherName": [
            "Retrobulbar( RB)",
            "Subtenon (ST)",
            "Intravenous (IV)"
      ],
      "InterventionType": [
            "Procedure"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Stem Cells",
            "Bone Marrow Derived Stem Cells",
            "BMSC",
            "Mesenchymal Stem Cells",
            "MSC",
            "Eye Disease",
            "Ophthalmology",
            "Ophthalmic Disease",
            "Retina",
            "Retinal Disease",
            "Macular Degeneration",
            "Age Related Macular Degeneration",
            "Myopic Macular Degeneration",
            "Geographic Atrophy",
            "Dry Macular Degeneration",
            "Wet Macular Degeneration",
            "Retinal Atrophy",
            "Retinal Dystrophy",
            "Hereditary Retinal Dystrophy",
            "Malattia Leventinese",
            "Retinitis Pigmentosa",
            "Stargardt Disease",
            "Cone Dystrophy",
            "Rod-Cone Dystrophy",
            "Cone-Rod Dystrophy",
            "Maculopathy",
            "Optic Nerve Disease",
            "Optic Atrophy",
            "Optic Neuropathy",
            "Ischemic Optic Neuropathy",
            "Optic Nerve Damage",
            "Optic Nerve Compression",
            "Compressive Optic Neuropathy",
            "Devics Syndrome",
            "Ushers Syndrome",
            "Neuromyelitis Optica",
            "Dominant Optic Atrophy",
            "Kjers Optic Atrophy",
            "Leber Hereditary Optic Neuropathy",
            "Blindness",
            "Vision Loss",
            "Retina Atrophy"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "August 3, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "August 1, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "MD Stem Cells"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Westport",
            "Coral Springs",
            "Dubai"
      ],
      "LocationContactEMail": [
            "stevenlevy@mdstemcells.com"
      ],
      "LocationContactName": [
            "Steven Levy, MD",
            "Steven Levy, MD",
            "Steven Levy, MD",
            "Jeffrey Weiss, MD",
            "Steven Levy, MD",
            "Steven Levy, MD"
      ],
      "LocationContactPhone": [
            "203-423-9494",
            "203-423-9494",
            "203-423-9494",
            "(001) 2034239494"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact",
            "Sub-Investigator",
            "Principal Investigator",
            "Contact",
            "Contact"
      ],
      "LocationCountry": [
            "United States",
            "United States",
            "United Arab Emirates"
      ],
      "LocationFacility": [
            "MD Stem Cells",
            "MD Stem Cells",
            "Medcare Orthopaedics & Spine Hospital"
      ],
      "LocationState": [
            "Connecticut",
            "Florida"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "06880",
            "33065"
      ],
      "MaximumAge": [],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "MD Stem Cells"
      ],
      "OrgStudyId": [
            "SCOTS2"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "MD Stem Cells",
            "Coral Springs"
      ],
      "OverallOfficialName": [
            "Steven Levy, MD",
            "Jeffrey Weiss, MD"
      ],
      "OverallOfficialRole": [
            "Study Chair",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Not Applicable"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2023"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Best corrected visual acuity will be measured with Snellen Eye Chart and the ETDRS (Early Treatment Diabetic Retinopathy Study)Eye Chart when available at each post- procedure visit. Intervals at minimum will be first post- procedure day,then 3 months, 6 months and 12 months post-procedure day. Recommended visit 1 month post -procedure day."
      ],
      "PrimaryOutcomeMeasure": [
            "Visual Acuity"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Change from pre-procedure to 12 months"
      ],
      "ReferenceCitation": [
            "Weiss JN, Levy S, Malkin A. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report. Neural Regen Res. 2015 Jun;10(6):982-8. doi: 10.4103/1673-5374.158365.",
            "Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy. Neural Regen Res. 2015 Sep;10(9):1507-15. doi: 10.4103/1673-5374.165525.",
            "Weiss JN, Benes SC, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment. Neural Regen Res. 2016 Sep;11(9):1512-1516.",
            "Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy. Neural Regen Res. 2016 Oct;11(10):1685-1694.",
            "Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem Cell Investig. 2017 Nov 23;4:94. doi: 10.21037/sci.2017.11.05. eCollection 2017.",
            "Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of Retinitis Pigmentosa. Stem Cell Investig. 2018 Jun 6;5:18. doi: 10.21037/sci.2018.04.02. eCollection 2018.",
            "Weiss JN, Levy S. Dynamic light scattering spectroscopy of the retina-a non-invasive quantitative technique to objectively document visual improvement following ocular stem cell treatment. Stem Cell Investig. 2019 Apr 1;6:8. doi: 10.21037/sci.2019.03.01. eCollection 2019.",
            "Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Usher syndrome. Stem Cell Investig. 2019 Sep 9;6:31. doi: 10.21037/sci.2019.08.07. eCollection 2019.",
            "Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy. Stem Cell Investig. 2019 Dec 5;6:41. doi: 10.21037/sci.2019.11.01. eCollection 2019.",
            "Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration. Medicines (Basel). 2020 Mar 28;7(4). pii: E16. doi: 10.3390/medicines7040016.",
            "Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease. Medicines (Basel). 2021 Feb 3;8(2). pii: 10. doi: 10.3390/medicines8020010."
      ],
      "ReferencePMID": [
            "26199618",
            "26604914",
            "27857759",
            "27904503",
            "29270420",
            "30050918",
            "31119146",
            "31620478",
            "32039263",
            "32231088",
            "33546345"
      ],
      "ReferenceType": [
            "result",
            "result",
            "result",
            "result",
            "result",
            "result",
            "result",
            "result",
            "result",
            "result",
            "result"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Visual fields will be evaluated with automated perimetry during post- procedure visits as needed and specifically at 6 months and 12 months. Visual fields are a key measurement in patients with peripheral vision loss.",
            "OCT thickness of the retinal nerve fiber layer the optic nerve and/or macula during the post- procedure visits as needed and specifically at 6 and 12 months - if available."
      ],
      "SecondaryOutcomeMeasure": [
            "Visual Fields",
            "Optical Coherence Tomography (OCT)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "Change from pre-procedure to 12 months",
            "Change from pre-procedure to 12 months"
      ],
      "SeeAlsoLinkLabel": [
            "Study Information"
      ],
      "SeeAlsoLinkURL": [
            "http://www.mdstemcells.com/scots-ii/"
      ],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2016"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "August 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "January 5, 2017"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "January 1, 2017"
      ]
}